The above-mentioned biomarkers were tested using ELISA kits and the results showed a significant reduction in the expression of RBP4, CXCL10 and NOX4 in the plasma of dogs affected by CCDS compared with normal dogs [34]. This evidence concerns the gene NOX4 and cerebral creatine deficiency syndrome.